POSTMENOPAUSE
Clinical trials for POSTMENOPAUSE explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSE trials appear
Sign up with your email to follow new studies for POSTMENOPAUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise plus hormones: a new hope for menopause health?
Disease control Recruiting nowThis study looks at whether combining supervised exercise with hormone replacement therapy helps postmenopausal women improve body composition, heart health, and insulin sensitivity. About 390 women with menopause symptoms who are eligible for hormone therapy will take part. Rese…
Matched conditions: POSTMENOPAUSE
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 05, 2026 12:04 UTC
-
Exercise before breast cancer surgery may fight fatigue and muscle loss
Symptom relief Recruiting nowThis study looks at whether starting resistance exercise training before breast cancer surgery can help reduce common side effects like fatigue, muscle loss, and reduced strength. The study involves 68 postmenopausal women with breast cancer who are scheduled for chemotherapy bef…
Matched conditions: POSTMENOPAUSE
Phase: NA • Sponsor: Universidad de La Frontera • Aim: Symptom relief
Last updated Jun 17, 2026 04:44 UTC
-
Can a simple supplement slow aging in postmenopausal women?
Symptom relief Recruiting nowThis study tests a dietary supplement called GLYLO in 30 postmenopausal women aged 45-65 who are overweight or have high blood sugar. The goal is to see if GLYLO can lower harmful compounds linked to aging and improve metabolism, hormone health, and physical function. Participant…
Matched conditions: POSTMENOPAUSE
Phase: NA • Sponsor: Buck Institute for Research on Aging • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC
-
Smoking may change how this drug works in postmenopausal women
Knowledge-focused Recruiting nowThis study tests whether smoking changes how the body processes a single dose of GS1-144 tablets. It involves 24 healthy Chinese women aged 40-65 who are postmenopausal. Researchers will measure drug levels in the blood to see if smoking affects the drug's breakdown. The goal is …
Matched conditions: POSTMENOPAUSE
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 17, 2026 04:39 UTC